Marathon Capital Management / JNJ
Marathon Capital Management’s Johnson & Johnson Position
Does Marathon Capital Management own Johnson & Johnson (JNJ)? Yes — 25.3K shares worth $6M (+1.39% of its 13F portfolio) as of Q1 2026, down from 26.2K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
25.3K
% of Portfolio
+1.39%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 25.3K | $6M | +1.39% |
| Q4 2025 | 26.2K | $5M | +1.17% |
| Q3 2025 | 28.7K | $5M | +1.22% |
| Q2 2025 | 29.2K | $4M | +1.14% |
| Q1 2025 | 29.4K | $5M | +1.30% |
| Q4 2024 | 29.9K | $4M | +1.08% |
| Q3 2024 | 29.7K | $5M | +1.17% |
| Q2 2024 | 29.7K | $4M | +1.11% |
| Q1 2024 | 28.7K | $5M | +1.08% |
| Q4 2023 | 28.6K | $4M | +1.13% |
| Q3 2023 | 28.4K | $4M | +1.11% |
| Q2 2023 | 36.0K | $6M | +1.47% |
| Q1 2023 | 36.4K | $6M | +1.39% |
| Q4 2022 | 36.9K | $7M | +1.80% |
| Q3 2022 | 36.9K | $6M | +1.72% |
| Q2 2022 | 26.4K | $5M | +1.51% |
| Q1 2022 | 26.5K | $5M | +1.35% |
| Q4 2021 | 26.5K | $5M | +1.06% |
| Q3 2021 | 27.3K | $4M | +1.00% |
| Q2 2021 | 26.1K | $4M | +0.99% |
| Q1 2021 | 26.5K | $4M | +1.15% |
| Q4 2020 | 25.6K | $4M | +1.19% |
| Q3 2020 | 26.0K | $4M | +1.41% |
| Q2 2020 | 27.8K | $4M | +1.50% |
| Q1 2020 | 27.9K | $4M | +1.68% |
| Q4 2019 | 29.0K | $4M | +1.44% |
| Q3 2019 | 22.4K | $3M | +1.17% |
| Q2 2019 | 22.7K | $3M | +1.29% |
| Q1 2019 | 22.5K | $3M | +1.40% |
| Q4 2018 | 22.8K | $3M | +1.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marathon Capital Management’s full portfolio or all institutional holders of JNJ.